Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![overnight_stock Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1941151648589434880.png) overnightstocks.com [@overnight_stock](/creator/twitter/overnight_stock) on x XXX followers
Created: 2025-07-22 10:26:26 UTC

📉 Oscar Health ($OSCR) drops preliminary Q2 results and cuts guidance | via
—

$OSCR flat pre-market — Oscar Health released preliminary Q2 results and revised its full-year 2025 outlook ahead of its August X earnings report:

Q2 operating loss: ~$230M

FY25 operating loss: now seen at $200M–$300M
Revenue forecast: cut to $12.0B–$12.2B
Medical Loss Ratio: raised to 86%–87% amid elevated risk scores and utilization
Adjusted EBITDA loss: expected to be ~$120M less than operating loss

Investors are digesting the impact of worsening margins and higher-than-expected costs.

![](https://pbs.twimg.com/media/GwdHnvaXMAEkuXe.png)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947604141397651784/c:line.svg)

**Related Topics**
[oscr](/topic/oscr)
[$122b](/topic/$122b)
[$120b](/topic/$120b)
[$300m](/topic/$300m)
[$200m](/topic/$200m)
[$230m](/topic/$230m)
[drops](/topic/drops)
[oscar](/topic/oscar)

[Post Link](https://x.com/overnight_stock/status/1947604141397651784)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

overnight_stock Avatar overnightstocks.com @overnight_stock on x XXX followers Created: 2025-07-22 10:26:26 UTC

📉 Oscar Health ($OSCR) drops preliminary Q2 results and cuts guidance | via —

$OSCR flat pre-market — Oscar Health released preliminary Q2 results and revised its full-year 2025 outlook ahead of its August X earnings report:

Q2 operating loss: ~$230M

FY25 operating loss: now seen at $200M–$300M Revenue forecast: cut to $12.0B–$12.2B Medical Loss Ratio: raised to 86%–87% amid elevated risk scores and utilization Adjusted EBITDA loss: expected to be ~$120M less than operating loss

Investors are digesting the impact of worsening margins and higher-than-expected costs.

XXXXX engagements

Engagements Line Chart

Related Topics oscr $122b $120b $300m $200m $230m drops oscar

Post Link

post/tweet::1947604141397651784
/post/tweet::1947604141397651784